BioSpace News Archive

BioAmber Restructures its Credit Facility With its Senior Lenders

This amendment to the loan agreement removes certain financial covenants under the terms of the loan agreement with the senior lenders, namely a minimum cash requirement and ongoing revenue covenants.

January 26, 2018
·
2 min read
Business

AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results

AbbVie announced financial results for the fourth quarter ended December 31, 2017.

January 26, 2018
·
46 min read
BioCapital

Senseonics Prices $50M Offering

BTIG is acting as the sole manager for the offering.

January 26, 2018
·
5 min read
BioMidwest

Stryker’s WEAVE Trial Demonstrates Positive Results of Endovascular Treatment for Patients With Intracranial Atherosclerotic Disease

Stryker’s sponsored WEAVE Trial is a multi-center, prospective, post-market surveillance study designed to evaluate the rate of stroke or death within 72 hours of the procedure in patients treated with the Wingspan Stent System.

January 26, 2018
·
4 min read
Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares – Jan. 26, 2018

Due to the conversion of the Convertible Capital Notes, the Company transfers 100,000 K shares owned by the Company to ABO.

January 26, 2018
·
1 min read
Owlstone Medical’s Breath Biopsy Wins Global IPF Catalyst Challenge

Owlstone Medical today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000,000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).

January 26, 2018
·
3 min read
Lone Star Bio

Premier Biomedical CEO Letter -- January, 2018

It has been a very busy and eventful quarter, and an exceptionally fruitful year, for Premier Biomedical.

January 26, 2018
·
7 min read
Biotech Bay

Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence

With increased adherence, the Company believes that patients with existing chronic conditions can better manage their health and prevent the onset of co-morbid conditions while facilitating a reduction in healthcare costs.

January 26, 2018
·
5 min read
Drug Development

Merus Announces First Patient Dosed in a Phase II Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations

Combination trial to evaluate MCLA-128 in HER2-positive and hormone receptor-positive/HER2-low metastatic breast cancer patients.

January 26, 2018
·
7 min read
IU School of Medicine Researchers Set New Record in NIH Funding In 2017

IU School of Medicine scientists and physicians brought in more than $135M in research funding from the NIH in federal fiscal year 2017.

January 26, 2018
·
2 min read